HemaCare updates regulatory status of HIV/AIDS clinical research.

Business Wire (November 21, 1994)

Linked as:

Extract

HemaCare updates regulatory status of HIV/AIDS clinical research.

LOS ANGELES--(HealthWire)--Nov. 21, 1994--HemaCare Corp. (NASDAQ:HEMA) Monday announced that a virus inactivation study of its manufacturing method for the...

See the full content of this document